Characterization of peptides bound to the class I MHC molecule HLA-A2. 1 by mass spectrometry DF Hunt, RA Henderson, J Shabanowitz, K Sakaguchi, H Michel, N Sevilir, ... Science 255 (5049), 1261-1263, 1992 | 1689 | 1992 |
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines AL Cox, J Skipper, Y Chen, RA Henderson, TL Darrow, J Shabanowitz, ... Science 264 (5159), 716-719, 1994 | 1151 | 1994 |
HLA-A2. 1-associated peptides from a mutant cell line: a second pathway of antigen presentation RA Henderson, H Michel, K Sakaguchi, J Shabanowitz, E Appella, ... Science 255 (5049), 1264-1266, 1992 | 692 | 1992 |
Cell-cell adhesion mediated by CD8 and MHC class I molecules AM Norment, RD Salter, P Parham, VH Engelhard, DR Littman Nature 336 (6194), 79-81, 1988 | 650 | 1988 |
Structure of peptides associated with class I and class II MHC molecules VH Engelhard Annual review of immunology 12 (1), 181-207, 1994 | 586 | 1994 |
Identification of a graft versus host disease-associated human minor histocompatibility antigen JMM den Haan, NE Sherman, E Blokland, E Huczko, F Koning, ... Science 268 (5216), 1476-1480, 1995 | 544 | 1995 |
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism JMM Den Haan, LM Meadows, W Wang, J Pool, E Blokland, TL Bishop, ... Science 279 (5353), 1054-1057, 1998 | 530 | 1998 |
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. JC Skipper, RC Hendrickson, PH Gulden, V Brichard, A Van Pel, Y Chen, ... The Journal of experimental medicine 183 (2), 527-534, 1996 | 528 | 1996 |
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. AY Huang, PH Gulden, AS Woods, MC Thomas, CD Tong, WEI Wang, ... Proceedings of the National Academy of Sciences 93 (18), 9730-9735, 1996 | 509 | 1996 |
Human HY: a male-specific histocompatibility antigen derived from the SMCY protein W Wang, LR Meadows, JMM den Haan, NE Sherman, Y Chen, ... Science 269 (5230), 1588-1590, 1995 | 431 | 1995 |
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating … CL Slingluff Jr, GR Petroni, GV Yamshchikov, DL Barnd, S Eastham, ... Journal of Clinical Oncology 21 (21), 4016-4026, 2003 | 420 | 2003 |
Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation JN Cohen, CJ Guidi, EF Tewalt, H Qiao, SJ Rouhani, A Ruddell, AG Farr, ... Journal of Experimental Medicine 207 (4), 681-688, 2010 | 403 | 2010 |
NKT cell activation mediates neutrophil IFN-γ production and renal ischemia-reperfusion injury L Li, L Huang, SJ Sung, PI Lobo, MG Brown, RK Gregg, VH Engelhard, ... The Journal of Immunology 178 (9), 5899-5911, 2007 | 392 | 2007 |
The HLA-A* 0201-restricted HY antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition L Meadows, W Wang, JMM den Haan, E Blokland, C Reinhardus, ... Immunity 6 (3), 273-281, 1997 | 351 | 1997 |
Structure of peptides associated with MHC class I molecules VH Engelhard Current opinion in immunology 6 (1), 13-23, 1994 | 347 | 1994 |
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation CM Lappas, YJ Day, MA Marshall, VH Engelhard, J Linden The Journal of experimental medicine 203 (12), 2639-2648, 2006 | 342 | 2006 |
Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy AL Zarling, JM Polefrone, AM Evans, LM Mikesh, J Shabanowitz, ... Proceedings of the National Academy of Sciences 103 (40), 14889-14894, 2006 | 301 | 2006 |
Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes CL Slingluff Jr, G Yamshchikov, P Neese, H Galavotti, S Eastham, ... Clinical Cancer Research 7 (10), 3012-3024, 2001 | 297 | 2001 |
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors ED Thompson, HL Enriquez, YX Fu, VH Engelhard Journal of Experimental Medicine 207 (8), 1791-1804, 2010 | 296 | 2010 |
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional … DW Mullins, SL Sheasley, RM Ream, TNJ Bullock, YX Fu, VH Engelhard The Journal of experimental medicine 198 (7), 1023-1034, 2003 | 289 | 2003 |